Clincosm LogoSign in Get a demo

enterovirus infections

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection, Rhinovirus Trial (Vapendavir, Placebo)

Not yet recruiting
  • COPD Exacerbation Acute
  • +35 more
  • (no location specified)
Nov 20, 2023

Enterovirus Infections, Influenza Trial in Hangzhou (EV71 vaccine and influenza vaccine, EV71 vaccine, influenza vaccine)

Completed
  • Enterovirus Infections
  • Influenza
  • EV71 vaccine and influenza vaccine
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang provincial center for disease control and prevention
Oct 10, 2022

Congenital Heart Disease, Viremia, Virus Diseases Trial in Saint Louis (Stool and Blood Specimen Collection, Follow-up Medical

Recruiting
  • Congenital Heart Disease
  • +14 more
  • Stool and Blood Specimen Collection
  • Follow-up Medical Record Review
  • Saint Louis, Missouri
  • +1 more
Aug 2, 2022

Pulmonary Disease, Chronic Obstructive, Enterovirus Infections, Rhinovirus Trial in Uppsala (CUR-N399, Placebo)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • +2 more
  • Uppsala, Sweden
    CTC Clinical Trial Consultants AB
Mar 22, 2022

Detection of Enterovirus Genotypes by CRISPR Technology

Not yet recruiting
  • Enterovirus Infections
  • Non-invasive detection method: CRISPR techonology
  • (no location specified)
Feb 10, 2022

Enterovirus Infections Trial in Taiwan, Vietnam (EV71 vaccine, Placebo)

Enrolling by invitation
  • Enterovirus Infections
  • EV71 vaccine
  • Placebo
  • Changhua, Taiwan
  • +7 more
Dec 5, 2021

Enterovirus Infections Trial in Taichung, Taipei, Taoyuan (EV71 vaccine ([0.5 µg total protein + adjuvant 150 µg AI(OH)3] per

Completed
  • Enterovirus Infections
  • EV71 vaccine ([0.5 μg total protein + adjuvant 150 μg AI(OH)3] per dose)
  • +2 more
  • Taichung, Taiwan
  • +3 more
Oct 18, 2021

Diabetes, Type I, Enterovirus Infections, Autoimmunity Trial in Oslo (GAD-alum, Placebo)

Terminated
  • Diabetes, Type I
  • +2 more
  • Oslo, Norway
    Endokrinologisk poliklinikk, Oslo Universitetssykehus Aker
May 14, 2018

Enterovirus Infections Trial in Taichung, Taipei, Tao Yuan (EV71 vaccine ([0.5 µg total protein + adjuvant 150 µg AIPO4] per

Completed
  • Enterovirus Infections
  • EV71 vaccine ([0.5 μg total protein + adjuvant 150 μg AIPO4] per dose)
  • +4 more
  • Taichung, Taiwan
  • +3 more
Nov 28, 2016

Hand, Foot, and Mouth Disease, Enterovirus Infections Trial in Lianyungang (160U /0.5ml, 320U /0.5ml, 640U /0.5ml)

Completed
  • Hand, Foot, and Mouth Disease
  • Enterovirus Infections
  • 160U /0.5ml
  • +3 more
  • Lianyungang, Jiangsu, China
    Donghai Center for Diseases Control and Prevention
Dec 30, 2011

Urinary Excretion of Enteroviruses FromPresumed Enteroviral

Completed
  • Enterovirus Infections
    • Bern, Switzerland
      Dept. Nephrology & Hypertension, Univ. Hospital Bern
    May 18, 2011